SPONSOR
Trogenix ltd
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Glioblastoma (GBM)High Grade GliomasRecurrent GlioblastomaNewly Diagnosed Glioblastoma
Trogenix ltd is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma, Newly Diagnosed Glioblastoma.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Trogenix ltd
How many clinical trials has Trogenix ltd sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Trogenix ltd, of which 1 are actively recruiting participants. These trials cover conditions including Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Trogenix ltd research focus on?
Trogenix ltd clinical trials span Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma, Newly Diagnosed Glioblastoma. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Trogenix ltd clinical trial?
To participate in a Trogenix ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Trogenix ltd trials with current recruitment status updated daily.
Clinical Trials by Trogenix ltd
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology